ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Affimed, Roche Explore AFM24, Tecentriq Combo contractpharma
February 04, 2021Affimed N.V., a clinical-stage immuno-oncology company, entered a clinical research collaboration with Roche to explore the combination of Affimed’s innate cell engager (ICE) AFM24 with Roche’s PD-L1 checkpoint inhibitor atezolizumab (Tecentriq).
Pharma Sources Insight January 2025
